期刊
MOVEMENT DISORDERS
卷 23, 期 -, 页码 S515-S520出版社
WILEY
DOI: 10.1002/mds.22146
关键词
Parkinson's disease; levodopa; toxicity; neuroprotection; dyskinesias
Levodopa is the 'gold standard' drug for the treatment of the motor symptoms of Parkinson's disease (PD), For many years there has been concern regarding, its potential to be toxic to the dopaminergic cells of the substantia nigra. Much of the evidence to support this is derived front in vitro studies and there are significant limitations in extrapolating these data to the clinic. Indeed, there is no evidence to indicate that levodopa is toxic to PD patients, and even some suggestion that it may be protective. (c) 2008 Movement Disorder Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据